Supuran CT |
Nanoparticles for controlled release of anti-biofilm agents WO2014130994 (A1): a patent evaluation. |
2015 |
Expert Opin Ther Pat |
pmid:26028186
|
Brilhante RS et al. |
Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol. |
2015 |
J. Med. Microbiol. |
pmid:25657300
|
Abdel-Rhman SH et al. |
Effect of Tyrosol and Farnesol on Virulence and Antibiotic Resistance of Clinical Isolates of Pseudomonas aeruginosa. |
2015 |
Biomed Res Int |
pmid:26844228
|
Kostoulias X et al. |
Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26482299
|
Hameiri-Grossman M et al. |
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth. |
2015 |
Oncotarget |
pmid:26393682
|
Lopez-Medina E et al. |
Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis. |
2015 |
PLoS Pathog. |
pmid:26313907
|
Joo JH et al. |
Farnesol activates the intrinsic pathway of apoptosis and the ATF4-ATF3-CHOP cascade of ER stress in human T lymphoblastic leukemia Molt4 cells. |
2015 |
Biochem. Pharmacol. |
pmid:26275811
|
Krause J et al. |
Prostaglandin E2 from Candida albicans Stimulates the Growth of Staphylococcus aureus in Mixed Biofilms. |
2015 |
PLoS ONE |
pmid:26262843
|
Katragkou A et al. |
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. |
2015 |
J. Antimicrob. Chemother. |
pmid:25288679
|
Strube-Bloss MF et al. |
Extracting the Behaviorally Relevant Stimulus: Unique Neural Representation of Farnesol, a Component of the Recruitment Pheromone of Bombus terrestris. |
2015 |
PLoS ONE |
pmid:26340263
|